Urine But Not Serum Soluble Urokinase Receptor (suPAR) May Identify Cases of Recurrent FSGS in Kidney Transplant Candidates

suPAR: The Molecular Crystal Ball

(2013) Maria Thunø et al.   DISEASE MARKERS

Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases

(2012) Andrea G. Kattah et al.   AUTOIMMUNITY REVIEWS

Soluble urokinase receptor and focal segmental glomerulosclerosis

(2012) Jochen Reiser et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Circulating suPAR in Two Cohorts of Primary FSGS

(2012) C. Wei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation

(2012) Vincent Audard et al.   TRANSPLANT INTERNATIONAL

Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

(2011) T. Sehestedt et al.   ATHEROSCLEROSIS

The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome

(2011) Gürdal Yilmaz et al.   CLINICAL BIOCHEMISTRY

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis: Outcomes and Response to Therapy for Recurrence

(2009) LaTonya J. Hickson et al.   TRANSPLANTATION